Trade GNLX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Genelux Corporation (GNLX) is trading at US$2.77, down 3.82% today as of Aug 28, 12:12 EDT. The company has a market capitalisation of US$123.07M. Over the past 52 weeks, GNLX has traded between US$2.29 and US$8.54. On Syfe you can trade GNLX with $0 commission and add it to your watchlist.
| Previous close | US$2.88 |
|---|---|
| Market cap | US$123.07M |
| 52-week range | US$2.29 – US$8.54 |
| Volume | 592.42K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Genelux Corporation
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay on September 4, 2001 and is headquartered in Westlake Village, CA.
Year: 2023
Genelux Corporation (GNLX) stock is trading at US$2.77, -3.82% from the previous close of US$2.88.
The market cap for Genelux Corporation (GNLX) stock is approximately US$123.07M.
The 52-week high for Genelux Corporation (GNLX) stock is US$8.54.
The 52-week low for Genelux Corporation (GNLX) stock is US$2.29.
Genelux Corporation (GNLX) does not currently pay a dividend.
Stay on top of GNLX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
